RVL Pharmaceuticals PLC expected to post a loss of 11 cents a share - Earnings Preview

RVL Pharmaceuticals

11/08/2023 16:40

* RVL Pharmaceuticals PLC  RVLP.OQ   RVLP.O  is expected
to show a
rise in quarterly revenue when it reports  results on August
14. 
    * The Bridgewater New Jersey-based  company is expected to
report 
a 25.7% increase in revenue to $10.619 million from $8.45
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for RVL Pharmaceuticals
PLC
is for a loss of 11 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for RVL
Pharmaceuticals PLC is $3​, above​ its last closing price
of $0.49. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.12       -0.12      -0.12     Met     -1.2
 Dec. 31 2023  -0.15       -0.16      -0.18     Missed  -12.7
 Sep. 30 2022  -0.15       -0.16      -0.16     Met     -0.5​
 Jun. 30 2022  -0.20       -0.21      -0.14     Beat    32.5
 ​​Mar.        -0.16       -0.17      -0.25     Missed  -45.6
 31 2022                                                
 Dec. 31 2021  -0.25       -0.27      -0.30     Missed  -12.5​
 Sep. 30 2021  -0.31       -0.31      -0.28     Beat    11.1
 Jun. 30 2021  -0.14       -0.14      -0.28     Missed  -100
 This summary was machine generated August 11 at 15:40 GMT.  All
figures in US dollars  unless otherwise stated